Intratumor Heterogeneity in Hepatocellular Carcinoma: Challenges and Opportunities
Hepatocellular carcinoma (HCC) represents a leading cause of cancer-related death, but it remains difficult to treat. Intratumor genetic and phenotypic heterogeneity are inherent properties of breast, skin, lung, prostate, and brain tumors, and intratumor heterogeneity (ITH) helps define prognosis a...
Guardado en:
Autores principales: | Sharanya Maanasi Kalasekar, Chad H. VanSant-Webb, Kimberley J. Evason |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/40e749afbae64edf93d626e3af8de048 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
A Portrait of Intratumoral Genomic and Transcriptomic Heterogeneity at Single-Cell Level in Colorectal Cancer
por: Andrea Angius, et al.
Publicado: (2021) -
Tumor Heterogeneity and Consequences for Bladder Cancer Treatment
por: Etienne Lavallee, et al.
Publicado: (2021) -
Intratumoral Heterogeneity and Immune Response Indicators to Predict Overall Survival in a Retrospective Study of HER2-Borderline (IHC 2+) Breast Cancer Patients
por: Gedmante Radziuviene, et al.
Publicado: (2021) -
Multiscale heterogeneity in gastric adenocarcinoma evolution is an obstacle to precision medicine
por: Christoph Röcken, et al.
Publicado: (2021) -
Advances in Injectable In Situ-Forming Hydrogels for Intratumoral Treatment
por: Gi Ru Shin, et al.
Publicado: (2021)